Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q2 '21 | Q3 '21 | Q2 '22 | |
|---|---|---|---|
| Value | $1.00M | $0.00 | $0.00 |
| QoQ Change | — | -100.0% | — |
| YoY Change | — | — | -100.0% |